A detailed history of Covestor LTD transactions in Mannkind Corp stock. As of the latest transaction made, Covestor LTD holds 22 shares of MNKD stock, worth $148. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Previous 23 4.35%
Holding current value
$148
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$5.01 - $6.7 $5 - $6
-1 Reduced 4.35%
22 $0
Q2 2024

Aug 09, 2024

SELL
$4.05 - $5.43 $4 - $5
-1 Reduced 4.17%
23 $0
Q1 2024

May 10, 2024

SELL
$3.25 - $5.27 $3 - $5
-1 Reduced 4.0%
24 $0
Q4 2023

Feb 09, 2024

SELL
$3.34 - $4.29 $6 - $8
-2 Reduced 7.41%
25 $0
Q3 2023

Nov 13, 2023

SELL
$3.91 - $5.45 $15 - $21
-4 Reduced 12.9%
27 $0
Q2 2023

Aug 11, 2023

BUY
$3.72 - $4.79 $115 - $148
31 New
31 $0
Q1 2022

May 13, 2022

SELL
$2.62 - $4.45 $280 - $476
-107 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$4.05 - $5.37 $433 - $574
107 New
107 $0

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.73B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.